Aptahem AB (publ) (NGM:APTA)
0.8560
-0.0280 (-3.17%)
At close: Feb 3, 2026
Aptahem AB Revenue
Aptahem AB had revenue of 303.00K SEK in the quarter ending September 30, 2025, a decrease of -53.10%. This brings the company's revenue in the last twelve months to 2.47M, down -78.30% year-over-year. In the year 2024, Aptahem AB had annual revenue of 3.77M, down -63.95%.
Revenue (ttm)
2.47M
Revenue Growth
-78.30%
P/S Ratio
7.58
Revenue / Employee
824.98K
Employees
3
Market Cap
18.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.77M | -6.69M | -63.95% |
| Dec 31, 2023 | 10.46M | 7.02M | 203.47% |
| Dec 31, 2022 | 3.45M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 22.65M |
| Fluicell AB | 13.20M |
| AcouSort AB | 10.80M |
| NanoEcho AB | 3.43M |
| 2cureX AB | 1.98M |
| Lipigon Pharmaceuticals AB | 1.32M |
| Pila Pharma AB | 957.89K |
| Stayble Therapeutics AB | -340.00K |